117 related articles for article (PubMed ID: 6251697)
1. The occurrence of the trehalose fermenting, tetracycline and polymyxin resistant phenotype among the Enterobacteriaceae.
Siboni K
Acta Pathol Microbiol Scand B; 1980 Aug; 88(4):185-8. PubMed ID: 6251697
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial resistance of the genera Proteus, Providencia and Serratia with special reference to multiple resistance patterns.
von Graevenitz A; Nourbakhsh M
Med Microbiol Immunol; 1972; 157(2):142-8. PubMed ID: 4554514
[No Abstract] [Full Text] [Related]
3. Correlation of the characters fermentation of trehalose, non-transmissible resistance to tetracycline, and relatively long flagellar wavelength in Proteus morganii.
Siboni K
Acta Pathol Microbiol Scand B; 1976 Dec; 84B(6):421-7. PubMed ID: 998259
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of gram-negative bacteria to polymyxin B nonapeptide.
Viljanen P; Vaara M
Antimicrob Agents Chemother; 1984 Jun; 25(6):701-5. PubMed ID: 6331296
[TBL] [Abstract][Full Text] [Related]
5. [Bactericidal activity and capacity for selection of mutants resistant to imipenmen and meropenem in strains of Proteus, Morganella and Providencia].
Villar HE; Longo L; Arena MF; Laurino G; Hoffman M
Enferm Infecc Microbiol Clin; 1998; 16(6):261-4. PubMed ID: 9763741
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of "enterobacteria" to aminoglycoside antibiotics: comparisons with tetracyclines, polymyxins, chloramphenicol, and spectinomycin.
Finland M; Garner C; Wilcox C; Sabath LD
J Infect Dis; 1976 Aug; 134 Suppl():S57-74. PubMed ID: 184213
[TBL] [Abstract][Full Text] [Related]
7. [Antimicrobial susceptibilities of clinical isolates of Morganella-proteus-providencia group of bacteria].
Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y
Jpn J Antibiot; 1991 Feb; 44(2):140-9. PubMed ID: 2041155
[TBL] [Abstract][Full Text] [Related]
8. Speciation, serotyping, antimicrobial sensitivity and plasmid content of Proteeae from the environment of calf-rearing units in South West England.
Hawkey PM; Penner JL; Linton AH; Hawkey CA; Crisp LJ; Hinton M
J Hyg (Lond); 1986 Dec; 97(3):405-17. PubMed ID: 3540110
[TBL] [Abstract][Full Text] [Related]
9. Combinations of antimicrobial agents: II. The in vitro sensitivity of 52 strains of proteus species to sulphafurazole, polymyxins and combinations of sulphafurazole and polymyxins.
Kuipers JS
Arch Chir Neerl; 1976; 28(1):33-41. PubMed ID: 180905
[TBL] [Abstract][Full Text] [Related]
10. Effect of polymyxins on the lipopolysaccharide-defective mutants of Proteus mirabilis.
Kaca W; Radziejewska-Lebrecht J; Bhat UR
Microbios; 1990; 61(246):23-32. PubMed ID: 2156134
[TBL] [Abstract][Full Text] [Related]
11. Species differences in susceptibilities of Proteeae spp. to six cephalosporins and three aminoglycosides.
Penner JL; Preston MA; Hennessy JN; Barton LJ; Goodbody MM
Antimicrob Agents Chemother; 1982 Aug; 22(2):218-21. PubMed ID: 6765415
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of trehalose fermentation and L-glutamic acid decarboxylation for identification of biochemically aberrant Providencia stuartii strains.
Fischer R; Penner JL; Zurinaga G; Riddle C; Sämisch W; Brenner DJ
J Clin Microbiol; 1989 Sep; 27(9):1969-72. PubMed ID: 2570791
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of different antibiotic actions combined with rifampicin. In vitro synergism against Pseudomonas and Proteus.
Urena MT; Barasoain I; Espinosa M; Garcia E; Portoles A
Chemotherapy; 1975; 21(2):82-9. PubMed ID: 169107
[TBL] [Abstract][Full Text] [Related]
14. Studies on the present state of resistance to framycetin among strains of staphylococci, enterobacteriaceae and pseudomonas.
Knothe H
Arzneimittelforschung; 1973 Dec; 23(12):1759-60. PubMed ID: 4205906
[No Abstract] [Full Text] [Related]
15. Genetic and biochemical diversity of ureases of Proteus, Providencia, and Morganella species isolated from urinary tract infection.
Jones BD; Mobley HL
Infect Immun; 1987 Sep; 55(9):2198-203. PubMed ID: 3623698
[TBL] [Abstract][Full Text] [Related]
16. [Current status of aminoglycoside resistance in hospital Enterobacteriaceae].
Ronco E; Migueres ML; Vacheron F; Guenounou M
Pathol Biol (Paris); 1988 May; 36(5):430-4. PubMed ID: 3043339
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
Meyer RD
J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
[TBL] [Abstract][Full Text] [Related]
18. Recognition of Morganella subspecies, with proposal of Morganella morganii subsp. morganii subsp. nov. and Morganella morganii subsp. sibonii subsp. nov.
Jensen KT; Frederiksen W; Hickman-Brenner FW; Steigerwalt AG; Riddle CF; Brenner DJ
Int J Syst Bacteriol; 1992 Oct; 42(4):613-20. PubMed ID: 1390112
[TBL] [Abstract][Full Text] [Related]
19. [Resistance patterns of certain Enterobacteriaceae in hospital and outpatients, with particular reference to trimethoprim-sulfamethoxazole (author's transl)].
Freitag V
MMW Munch Med Wochenschr; 1976 Feb; 118(9):275-8. PubMed ID: 817195
[TBL] [Abstract][Full Text] [Related]
20. [Susceptibility of Enterobacteriaceae rods to selected tetracyclines].
Sekowska A; Ibsz-Fijałkowska A; Gołdyn K; Gospodarek E
Med Dosw Mikrobiol; 2009; 61(4):321-6. PubMed ID: 20201321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
